Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Equity

Contineum Therapeutics (CTNM) Return on Capital Employed (2024)

Historic Return on Capital Employed for Contineum Therapeutics (CTNM) over the last 1 years, with Q4 2024 value amounting to 0.25%.

  • Contineum Therapeutics' Return on Capital Employed changed N/A to 0.25% in Q4 2024 from the same period last year, while for Dec 2024 it was 0.25%, marking a year-over-year change of. This contributed to the annual value of 0.31% for FY2024, which is N/A changed from last year.
  • As of Q4 2024, Contineum Therapeutics' Return on Capital Employed stood at 0.25%.
  • Contineum Therapeutics' 5-year Return on Capital Employed high stood at 0.09% for Q1 2024, and its period low was 0.25% during Q4 2024.